San Francisco, CA—Percutaneous closure of the patent ductus arteriosus (PDA) in children using a novel device is safe and effective, according to a prospective study presented in a featured clinical ...

Abbott announced that the FDA approved a closure device for the treatment of premature babies with patent ductus arteriosus who are nonresponsive to medical management. The Amplatzer Piccolo occluder ...

Failure to medical therapy Contraindicated to medical therapy (presence of kidney dysfunction, and decreased platelet count) Congestive Heart failure PDA diagnosed in an older infant. PDA that not are ...

LOS ANGELES, CA — A transcatheter technique using primarily echocardiographically guided patent ductus arteriosus (PDA) closure in extremely premature newborns (EPNs) can be performed safely and with ...

New Delhi: Doctors at Fortis Escorts Heart Institute, Okhla successfully conducted a rare procedure to save the life of a 1.5-month-old newborn weighing mere 1.8 kgs, who was suffering from patent ...

“This position statement represents a collective effort between neonatology, anesthesia, and interventional cardiology to provide comprehensive guidance on tcPDA device occlusion that can be adapted ...

KUALA LUMPUR, Malaysia, June 6, 2025 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) marked a significant milestone in cardiovascular care with the successful transcatheter device occlusion of a ...

In 2019, the U.S. Food and Drug Administration approved the first PDA occlusion device for infants as small as 700 grams, leading to rapid adoption of tcPDA in premature infants. Catheter-based ...

Kolkata: A premature newborn girl, weighing only 720 g, underwent a cardiac procedure—that is usually considered for babies only after they have attai.